Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glomed Pharmaceuticals is a prominent Vietnamese pharmaceutical company that specializes in the manufacturing and distribution of generic medicines. Founded in 1995, the company has established itself as a leading domestic player with a diverse portfolio covering therapeutic areas such as antibiotics, cardiovascular health, and gastroenterology. In 2016, Glomed was acquired by the global healthcare leader Abbott, a move that significantly bolstered Abbott's presence in the emerging Vietnamese market. The company operates two major manufacturing facilities in Binh Duong province, both of which adhere to Good Manufacturing Practice (GMP) standards. Today, Glomed functions as a key component of Abbott's Established Pharmaceuticals Division, focusing on providing high-quality and affordable healthcare solutions to patients across Vietnam and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glomed Pharmaceuticals.